{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Cedars-Sinai
Cedars-Sinai
  • Sign In
  • Live Activities
  • On-Demand Activities
  • Grand Rounds and RSS
  • CE Planning Process
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Use My Cedars Login
Login with my CloudCME™ account
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Forgot Your Password?

Login Tips: 
PLEASE CREATE AN ACCOUNT IF:

• You have never attended a Cedars-Sinai CE activity
• OR You are a NEW member of the Cedars-Sinai Medical Staff since August 2023

If you do NOT meet either of the criteria above, please DO NOT CREATE AN ACCOUNT:

• If you do not know which email address is used for your account, please contact the Cedars-Sinai Office of CME.
• Accounts for existing Cedars-Sinai Medical Staff (prior to August 2023) use the primary email on file with the Medical Staff Office.

For ALL USERS: If you do not have the password for your account, click the "Forgot Your Password?" link.

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ATC
  • BSN
  • CCC-SLP
  • CCLS
  • CPhT
  • CRNA
  • CRT
  • DC
  • DDS
  • DMD
  • DNAP
  • DNP
  • DO
  • DPM
  • LCGC
  • LCSW
  • LVN
  • MBBCh
  • MBBS
  • MD
  • MD, PhD
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • NP
  • OT
  • Other
  • OTR/L
  • PA
  • PharmD
  • PhD
  • PsyD
  • PT
  • RD
  • RN
  • RN, BSN
  • RPh
  • RRT
  • RT
  • RVT
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

12th Annual New Therapeutics in Oncology: The Road to Personalized Medicine


12th Annual New Therapeutics in Oncology: The Road to Personalized Medicine Banner

  • Overview
  • Faculty
  • Schedule
  • Exhibitor Registration
Add to Calendar 12th Annual New Therapeutics in Oncology: The Road to Personalized Medicine 11/10/2023 1:30:00 PM 11/11/2023 4:00:00 PM America/Los_Angeles For More Details: https://cedars.cloud-cme.com/oncologycme23 Description: This important educational activity will provide guidance to front-line and oncology clinicians, nurses, physicians, pharmacists, nurse practitioners, physician assistants and pharmacists, with the most current information available about new agents in oncology and translating of the latest research to their patients. The conference will cover drug and treatment updates with a focus on precision medicine, gynecological... Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard false MM/DD/YYYY


Date & Location
Friday, November 10, 2023, 1:30 PM - Saturday, November 11, 2023, 4:00 PM PST, Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard, Los Angeles, CA

Target Audience
Specialties - Hematology, Internal Medicine, Oncology, Pain Management, Radiation Oncology, Surgery
Professions - Nurse, Nurse (Advanced Practice NP CRNA CNM CNS), Pharmacist, Physician, Physician Assistant, Researcher (physician)

Overview
This important educational activity will provide guidance to front-line and oncology clinicians, nurses, physicians, pharmacists, nurse practitioners, physician assistants and pharmacists, with the most current information available about new agents in oncology and translating of the latest research to their patients. The conference will cover drug and treatment updates with a focus on precision medicine, gynecological malignancies, hematologic malignancies, prostate, bladder cancer and GI malignancies. The conference features a comprehensive review of new drugs approved along with their mechanism of action, and a keynote lecture, Stand Up to Cancer focusing on developmental therapeutics. Next generation studies will also be addressed, and the conference will offer participants a session designed to provide insight into the latest advances in lung cancer treatment, including integration of new molecularly-targeted therapies and immunotherapy.

Objectives
  1. Evaluate new, emerging and novel therapeutic agents, advances in care, and clinical trial data and apply relevant findings into the management of cancer patients
  2. Develop personalized treatment plans for patients based upon an evaluation of efficacy and safety of current and newly approved agents and therapeutic options
  3. Integrate appropriate strategies into clinical practice to optimize the management of patients with gynecologic malignancies to improve patient outcomes
  4. Utilize AJCC or other appropriate staging in clinical practice, including appropriate prognostic indicators and evidence-based national guidelines for treatment planning
  5. Review the principles, techniques, and applications of precision medicine, including genomic and molecular profiling, biomarker discovery, targeted therapies, and personalized care, in order to appreciate the potential benefits, limitations, and ethical considerations of this emerging approach to healthcare.

Registration

Physicians: : $129
Pharmacists: $79
Industry: $229
Healthcare professionals-Nurses, Residents/Fellows, Medical students, C-S associated healthcare professionals: Free

Refund Policy
All cancellations must be submitted in writing and refunds will be subject to an administrative charge. To view the policy, click here. Please e-mail cancellation request to [email protected]. If you do not receive confirmation of your cancellation via e-mail, please call (310) 423-5548.  


Disclaimer
All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner without the express permission of Cedars-Sinai.

Right to Cancel or Postpone
Cedars-Sinai reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event that Cedars-Sinai must cancel or postpone this course, the registration fee will be fully refunded. Cedars-Sinai is not responsible for any related costs, charges or expenses to participants, including fees assessed by airline, travel or lodging agencies.

Health and Safety Protocol
Before registering for this event, please read our Health and Safety Protocol for current requirements pertaining to attending in-person events.



Accreditation

Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Cedars-Sinai Medical Center designates this Live Activity for a maximum of 9.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician Attendance
A certificate of participation will be provided to other health care professionals requesting credits. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.

Credits
AMA PRA Category 1 Credit(s)™ (MD, DO) (9.50 hours), Non-Physician AMA Attendance (9.50 hours)


Keywords: LIVEAMA
The registration form for this activity is currently unavailable.



Mitigation of Relevant Financial Relationships


Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Robert A. Figlin, MD
Cedars-Sinai
Course Director, Faculty
Nothing to disclose
Faculty Photos
Alain Mita, MD
Cedars-Sinai
Course Director, Faculty
Nothing to disclose
Faculty Photos
Monica M. Mita, MD
Cedars-Sinai
Course Director, Faculty
Nothing to disclose
Ross Camidge, MD, PhD
University of Colorado Medicine
Faculty
Advisor-Abbvie |Advisor-Anheart|Advisor-AstraZeneca|Advisor-Appolomics|Advisor-Amgen|Advisor-Aveo|Advisor-Beigene|Advisor-Bio-Thera|Advisor-Bio-Thera|Advisor-Coherus|Advisor-Daiichi-Sankyo|Advisor-Eli Lilly|Advisor-EMD Serono|Advisor-Elevation|Advisor-Gilead|Advisor-Helsinn|Advisor-Hengrui|Advisor-Hummingbird|Advisor-Imagene|Advisor-Immunocore|Advisor-Janssen|Advisor-Kestrel |Advisor-Merck KGa|Advisor-Medtronic|Advisor-Mersana|Advisor-Mirati|Advisor-Nalo Therapeutics|Advisor-Nuvalent|Advisor-Prelude|Advisor-Puma |Advisor-Onkure|Advisor-Regeneron|Advisor-Roche|Advisor-Ribon|Advisor-Sanofi|Advisor-Seattle Genetics|Advisor-Takeda|Advisor-Turning Point|Advisor-Theseus|Advisor-Valence|Advisor-Xcovery|PrincipalNamedInvestigator-Abbvie|PrincipalNamedInvestigator-AstraZeneca|PrincipalNamedInvestigator-Blueprint|Advisor-Dizal|PrincipalNamedInvestigator-Inhibrx|Advisor-Karyopharm|PrincipalNamedInvestigator-Nuvalent|PrincipalNamedInvestigator-Pfizer|PrincipalNamedInvestigator-Phosplatin|PrincipalNamedInvestigator-Psioxus|PrincipalNamedInvestigator-Rain|PrincipalNamedInvestigator-Roche-Genentech|PrincipalNamedInvestigator-Seattle Genetics|PrincipalNamedInvestigator-Takeda|PrincipalNamedInvestigator-Turning Point|PrincipalNamedInvestigator-Verastem
Kjirsten Carlson, MD
Cedars Sinai Medical Center
Faculty
Nothing to disclose
Faculty Photos
Justin Darrah, MD
Cedars-Sinai
Faculty
Nothing to disclose
Stephen J. Freedland, MD
Cedars-Sinai
Faculty
Advisor-AstraZeneca|Advisor-Merck and Company, Inc.|Advisor-Eli Lilly and Company|Advisor-Pfizer, Inc.|Advisor-Astellas|Advisor-Bayer Corporation|Advisor-Myovant|Advisor-Sanofi-Aventis|Advisor-Janssen|Advisor-Boston Scientific Corporation
Sara Ghandehari, MD
CSMC
Faculty
Nothing to disclose
Faculty Photos
Omid Hamid, MD
The Angeles Clinic and Research Institute
Faculty
Advisor-Alkermes, Amgen, Bactonix, Beigene, Bioatla, BMS, Esai, Roche Genentech|Advisor-Georgiamune, GigaGen, Grit Bio, GSK, Idera, Immunocore, Incyte|Advisor- Instilbio, IO Bio, Iovance, Janssen, KSQ, Merck, Moderna, Novartis, Obsidian|Advisor-Pfizer, Regeneron, Sanofi, Seattle Gen, Tempus, Vial Health, Zelluna|Speaker- BMS, Immunocore, Novartis, Pfizer, Regeneron|StockPrivate-Bactonix|Other: Contracted Research-Arcus, Aduro, Akeso, Amgen, Bioatla, BMS,|Other: Contracted Research-Cytomx, Exelixis, Roche Genentech, GSK|Other: Contracted Research-Immunocore, Idera, Incyte, Iovance, Merck|Other: Contracted Research-Moderna, Merck Serono, NextCure|Other: Contracted Research-Novartis, Pfizer, Regeneron, Seattle Gen, Torque, Zelluna
Faculty Photos
Jethro Hu, MD
Cedars-Sinai Medical Center
Faculty
Nothing to disclose
Hyung L. Kim, MD
Cedars-Sinai Medical Center
Faculty
Advisor-Crown Bioscience|Speaker-Focal One|Other: Paid travel-Histosonics (Relationship has ended)
Razelle Kurzrock, MD
Medical College of Wisconsin
Faculty
Independent ContractorResearcher-Biological Dynamics|Independent ContractorResearcher-National Cancer Institute|Independent ContractorResearcher-Boehringer Ingelheim|Independent ContractorResearcher-Debiopharm|Independent ContractorResearcher-Foundation Medicine|Independent ContractorResearcher-Genentech|Independent ContractorResearcher-Grifols|Independent ContractorResearcher-Guardant|Independent ContractorResearcher-Incyte|Independent ContractorResearcher-Konica Minolta|Independent ContractorResearcher-Medimmune|Independent ContractorResearcher-Merck Serono|Independent ContractorResearcher-Omniseq|Independent ContractorResearcher-Pfizer|Independent ContractorResearcher-Sequenom|Independent ContractorResearcher-Takeda|Independent ContractorResearcher-TopAlliance|Consultant-Actuate Therapeutics|Consultant-AstraZeneca|Consultant- Bicara Therapeutics|Consultant-Biological Dynamics|Consultant-Caris|Consultant-Datar Cancer Genetics|Consultant-Daiichi Sankyo, Inc.|Consultant-EISAI|Consultant-EOM Pharmaceuticals|Consultant-Iylon|Consultant-Merck|Consultant-NeoGenomics|Consultant-Prosperdtx|Consultant-Regeneron|Consultant- Neomed|Consultant-Pfizer|Other: Precirix: consultant and/or speaker fees and/or advisory board/consultant-Precirix|Consultant-Prosperdtx|Consultant-Roche|Consultant-TD2 Volastra|Consultant-Turning Point Therapeutics|Consultant-X-Biotech|Other: Equity Interest, Serves on the Board, Co-Founder-CureMatch, Inc. |Other: Serves on the Board-CureMetrix|Other: Equity Interest-IDbyDNA|Other: Dr. Kurzrock has received research funding from NCI-NCI|Other: Labcorp: consultant and/or speaker fees and/or advisory board/consultant-Labcorp
Leo Mascarenhas, MD
Cedars-Sinai Medical Center
Faculty
Consultant-AMGEN (Relationship has ended)|Advisor-Gilead (Relationship has ended)
Faculty Photos
Arsen Osipov, MD
Cedars-Sinai
Faculty
Nothing to disclose
Karen Reckamp, MD
Cedars-Sinai
Faculty
Consultant-Amgen (Relationship has ended)|Consultant-Mirati (Relationship has ended)|Consultant-Janssen|Consultant-Genentech, Inc.|Consultant-EMD Serono (Relationship has ended)|Consultant-GlaxoSmithKline|Consultant-Merck KGA (Relationship has ended)|Consultant-Blueprint (Relationship has ended)|PrincipalNamedInvestigator-Elevation Oncology|PrincipalNamedInvestigator-Daiichi Sankyo|PrincipalNamedInvestigator-Blueprint|PrincipalNamedInvestigator-Calithera (Relationship has ended)|PrincipalNamedInvestigator-Genentech, Inc.|PrincipalNamedInvestigator-Janssen
Faculty Photos
Bobbie Rimel, MD
Cedars-Sinai
Faculty
Consultant-GSK|Consultant-AstraZeneca (Relationship has ended)|Consultant-Deep6AI (Relationship has ended)
Nicholas Tatonetti, PhD, MS
Cedars-Sinai
Faculty
Nothing to disclose
Debasish Tripathy, MD
The University of Texas, MD Anderson Cancer Clinic
Faculty
Consultant-AMBRX|Consultant-AstraZeneca|Consultant-Stemline|Consultant-Novartis AG|Consultant-Pfizer, Inc.|PrincipalNamedInvestigator-Novartis AG|Consultant-Puma Biotechnology|Consultant-Roche|Consultant-Sermonix
Faculty Photos
Eric Vail, MD
Cedars-Sinai
Faculty
Speaker-Bayer Corporation|Speaker-Pfizer, Inc.|Consultant-Sanofi-Aventis|Speaker-Eli Lilly and Company|Speaker-Johnson and Johnson|Speaker-AstraZeneca|Consultant-PierianDx|Consultant-Thermo Fisher Scientific|Consultant-Illumina|Consultant-Tempus|Consultant-Caris|Independent ContractorResearcher-LungLifeAI
Faculty Photos
Kristopher Wentzel, MD
The Angeles Clinic
Faculty
Nothing to disclose
Mohamed Ahmed, MD
Cedars-Sinai
Reviewer
Nothing to disclose
Faculty Photos
Matthew Ebia, MD
Cedars Sinai
Reviewer
Nothing to disclose

Friday, November 10, 2023
Registration Check In
1:30PM - 2:00PM
 
General Session - Friday Afternoon

Chairs: Robert A Figlin, MD and Monica M. Mita, MD
Opening Remarks
2:00PM - 2:10PM
Robert A. Figlin, MD
New developments in the treatment of gynecological malignancies
2:10PM - 2:30PM
Bobbie Rimel, MD
Q&A
2:30PM - 2:40PM
Use of BIG DATA for advancing precision medicine
2:40PM - 3:00PM
Nicholas Tatonetti, PhD, MS
Q&A
3:00PM - 3:10PM
 
Cancer screening in the 21st century: new advances

Lung cancer screening
3:10PM - 3:25PM
Sara Ghandehari, MD
Breast cancer screening
3:25PM - 3:40PM
Kjirsten Carlson, MD
Prostate cancer screening
3:40PM - 3:55PM
Hyung L. Kim, MD
New blood-based test for cancer screening
3:55PM - 4:15PM
Eric Vail, MD
Q&A
4:15PM - 4:35PM
 
Networking Reception and Cocktails

Networking Reception and Cocktails
4:35PM - 6:00PM
Saturday, November 11, 2023
Registration Check In
7:30AM - 8:00AM
 
General Session - Saturday Morning

Chairs: Robert A Figlin, MD and Razelle Kurzrock, MD
Opening Remarks
8:00AM - 8:10AM
New drugs approved in 2023 and their mechanism of action
8:10AM - 8:40AM
Alain Mita, MD
Q&A
8:40AM - 8:50AM
Lung cancer as a paradigm for precision medicine
8:50AM - 9:20AM
Ross Camidge, MD, PhD
Q&A
9:20AM - 9:30AM
Expert Updates in Hematologic Malignancies
9:30AM - 9:50AM
Justin Darrah, MD
Q&A
9:50AM - 10:00AM
Break and Exhibits
10:00AM - 10:20AM
 
Advances of precision medicine in rare tumors

Precision Medicine for Sarcoma
10:20AM - 10:40AM
Leo Mascarenhas, MD
Cholangiocarcinoma
10:40AM - 11:00AM
Arsen Osipov, MD
Brain tumors
11:00AM - 11:20AM
Jethro Hu, MD
Q&A
11:20AM - 11:30AM
 
General Session - Saturday Afternoon

Chairs: Alain Mita, MD and Karen Reckamp, MD
From Tissue Agnostic to N-of-1: (R)evolution of the Precision Paradigm
11:30AM - 11:50AM
Razelle Kurzrock, MD
Q&A
11:50AM - 12:00PM
Lunch and Exhibits
12:00PM - 1:00PM
Immunotherapy, immunoconjugates and novel hormone therapies: the revolution for breast cancer treatments
1:00PM - 1:45PM
Debasish Tripathy, MD
Q&A
1:45PM - 2:00PM
Bi-specific antibodies as a promising new strategy for precision medicine
2:00PM - 2:20PM
Omid Hamid, MD
Q&A
2:20PM - 2:30PM
Break and Exhibits
2:30PM - 2:50PM
Paradigm change in clinical trial design: From LUNGMAP to PRAGMATICA lung trials
2:50PM - 3:20PM
Karen Reckamp, MD
Q&A
3:20PM - 3:30PM
 
State-of-the-art for GU malignancies treatment

Renal Cancer
3:30PM - 3:45PM
Robert A. Figlin, MD
Prostate Cancer
3:45PM - 4:00PM
Stephen J. Freedland, MD
Bladder Cancer
4:00PM - 4:15PM
Kristopher Wentzel, MD
Q&A
4:15PM - 4:30PM

Oncology 2023-Exhibitors by Cedars-Sinai CME
Contact Us:
CME Office Cedars-Sinai
CME

Email: [email protected]
Website: https://cedars.cloud-cme.com/oncologycme



Exhibitor Packages

Exhibitor Package - Exhibit fee Price: $2500.00
Includes:
  • (1) 6ft Table Top, includes 2 chairs
  • Number of Exhibitor Badges: 2

Deadline for order commitment is 10/27/2023 12:00:00 AM.


CE Disclosure Form  | CE Application  | Privacy  |  Cedars-Sinai CME Homepage

Contact Us: [email protected]

        

© 2025 Cedars-Sinai. All Rights Reserved. A 501(c)(3) non-profit organization